Bayview Pharmacy is pleased to present our unique formulation of Doxylamine Succinate 20 mg/Pyridoxine HCl 100 mg Slow Release Capsules. This innovative formulation is designed to provide extended relief from a range of conditions, including nausea, vomiting, motion sickness, morning sickness, premenstrual syndrome, and other conditions associated with hormonal imbalances.

Our slow-release capsules are formulated with Methocel E4M, a type of controlled-release polymer. This advanced technology ensures the gradual release of the encapsulated medication over an extended period of time. This sustained release offers consistent therapeutic effects, reduces the need for frequent dosing, and improves patient compliance, particularly for medications requiring a controlled and prolonged release profile.

The combination of doxylamine succinate and pyridoxine HCl in our formulation works synergistically to alleviate the severity of symptoms and provide relief for extended periods. This makes our formulation an excellent choice for patients requiring long-term symptom management.

Our slow-release capsules are also a valuable option for healthcare providers seeking to offer their patients a safe and effective treatment option. The controlled release of the active ingredients ensures a steady therapeutic effect, enhancing the overall treatment outcome.

If you have any queries about this formulation or any of our other compounding services, please feel free to contact us. Our team is committed to assisting you in finding the most suitable solution for your patients' needs.

This formulation of Doxylamine Succinate 20 mg/Pyridoxine HCl 100 mg Slow Release Capsules, compounded with Methocel E4M, is specifically designed to provide a controlled and prolonged release of the active ingredients. This unique formulation is primarily used for the treatment of nausea and vomiting associated with pregnancy, including morning sickness. It may also be beneficial in managing conditions such as insomnia, anxiety, and depression.

Patients are advised to take this medication as directed by their healthcare provider, ideally at the same time each day, preferably in the evening. It is crucial not to exceed the recommended dose and not to continue the medication for more than two weeks without consulting with a healthcare provider.

It is important to note that this formulation may cause drowsiness. Therefore, patients should refrain from driving or operating machinery until they fully understand how this medication affects them. This formulation may also interact with other medications, including but not limited to antacids, anticonvulsants, and anticoagulants. It is essential for patients to inform their healthcare provider of all medications they are currently taking before starting this formulation.

Healthcare providers should exercise caution when prescribing this formulation to patients with a history of depression, anxiety, or other mental health conditions due to its potential to cause drowsiness. Additionally, this formulation's potential interactions with other medications, particularly antacids, anticonvulsants, and anticoagulants, should be taken into consideration.

If you have any questions or concerns about this formulation or its potential interactions, please do not hesitate to contact your healthcare provider for further information and guidance.

Doxylamine Succinate 20 mg/Pyridoxine HCl 100 mg Slow Release Capsules are a compounded formulation designed to treat a variety of conditions such as nausea and vomiting, insomnia, and premenstrual syndrome. The active ingredients in this formulation are doxylamine succinate, an antihistamine that works by blocking the action of histamine, and pyridoxine hydrochloride, a form of vitamin B6 that aids in the production of serotonin, a neurotransmitter that helps regulate mood and sleep.

This formulation is encapsulated with Methocel E4M, a type of controlled-release polymer. This polymer is designed to gradually release the encapsulated medication over an extended period of time. This slow release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications that require a controlled and prolonged release profile.

The recommended dose for this formulation is one capsule taken orally once daily, preferably at bedtime. It is crucial to follow the instructions provided by your healthcare provider and not to exceed the recommended dose. Additionally, it is important to avoid taking this medication with alcohol or other medications that may cause drowsiness, as this can enhance the sedative effects of doxylamine succinate.

If you have any questions about this formulation or its mechanism of action, it is recommended to consult with your healthcare provider or pharmacist. They can provide you with the most accurate and personalized information based on your specific health condition and medication needs.

This compounded formulation of Doxylamine Succinate 20 mg/Pyridoxine HCl 100 mg Slow Release Capsules is designed with Methocel E4M, a controlled-release polymer. This innovative design allows for the gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects. This slow-release mechanism can lead to reduced dosing frequency, enhancing patient compliance, particularly for medications requiring a controlled and prolonged release profile.

The Doxylamine Succinate component of this formulation is commonly used to alleviate symptoms of motion sickness, such as dizziness, nausea, and vomiting. It can also be beneficial in managing symptoms of premenstrual syndrome, including irritability, mood swings, and anxiety. Furthermore, it may be used to address symptoms of restless leg syndrome, such as an urge to move the legs, tingling or burning sensations in the legs, and difficulty sleeping.

The Pyridoxine HCl component, a form of vitamin B6, can be used to treat anemia caused by a deficiency of this vitamin. It is essential for the production of hemoglobin, the protein in red blood cells that carries oxygen throughout the body. A deficiency in vitamin B6 can lead to a specific type of anemia, and this formulation can help address that.

If you have any questions about the uses of this formulation, please consult with a healthcare professional. It is important to use this medication as directed by a healthcare provider to ensure its safety and efficacy.